PMID: 2494292Mar 1, 1989Paper

Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components

The Journal of Experimental Medicine
K IidaV Nussenzweig

Abstract

We studied the effect of complement on two life cycle stages of the protozoan parasite Trypanosoma cruzi: epimastigotes, found in the insect vector, and amastigotes, found in the mammalian host. We found that while both stages activate vigorously the alternative pathway, only epimastigotes are destroyed. The amounts of C3 and C5b-7 deposited on the amastigotes were similar to those bound to the much larger epimastigotes. Binding of C9 to amastigotes was four to six times less than binding to epimastigotes, resulting in a lower C9/C5b-7 ratio. Although a fairly large amount of C9 bound stably to amastigotes, no functional channels were formed as measured by release of incorporated 86Rb. The bound C9 had the characteristic properties of poly-C9, that is, it expressed a neo-antigen unique to poly-C9, and migrated in SDS-PAGE with an apparent Mr greater than 10(5). The poly-C9 was removed from the surface of amastigotes by treatment with trypsin, indicating that it was not inserted in the lipid bilayer. Modification of amastigote surface by pronase treatment rendered the parasites susceptible to complement attack. These results suggest that amastigotes have a surface protein that binds to the C5b-9 complex and inhibits membrane ins...Continue Reading

References

Jul 1, 1975·The Journal of Experimental Medicine·N NogueiraZ Cohn
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L S ZalmanH J Müller-Eberhard
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K JoinerC Hammer
Aug 1, 1988·The Journal of Experimental Medicine·V LeyV Nussenzweig
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M T RimoldiK Joiner
Jan 1, 1986·Annual Review of Immunology·H J Müller-Eberhard
Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K A JoinerM M Frank
Oct 1, 1970·The Journal of Experimental Medicine·N R Cooper, H J Müller-Eberhard
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·L E RammM M Mayer
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·T L KipnisW D da Silva

❮ Previous
Next ❯

Citations

Jan 1, 1994·Springer Seminars in Immunopathology·M C Moffitt, M M Frank
Jan 1, 1994·Springer Seminars in Immunopathology·Z Fishelson
May 1, 1989·Experimental Parasitology·S A Fuhrman, K A Joiner
Oct 1, 1989·Current Opinion in Immunology·G D Ross
Mar 1, 1991·Immunology Today·B F Hall, K A Joiner
Oct 17, 2006·Parasitology Today·S Tomlinson, J Raper
May 1, 1994·The Journal of Experimental Medicine·M ParizadeZ Fishelson
Nov 1, 1995·The Journal of Experimental Medicine·S KahnM Kahn
Jul 1, 1995·Scandinavian Journal of Immunology·T S JokirantaS Meri
Sep 29, 2009·Molecular Immunology·Igor dos S CestariMarcel I Ramirez
Feb 28, 2017·Molecular Microbiology·Rafael Luis KesslerChristian Macagnan Probst
Jan 1, 1997·Revista Do Instituto De Medicina Tropical De São Paulo·M de L Higuchi
Feb 5, 2005·Anais Da Academia Brasileira De Ciências·Renato A MortaraSolange da Silva
Jun 10, 2000·Memórias do Instituto Oswaldo Cruz·J Scharfstein, A Morrot
Sep 1, 1991·Immunology Today·N R Cooper
Nov 6, 2013·Infection and Immunity·Claudia HammerschmidtPeter Kraiczy
Jan 1, 1993·Springer Seminars in Immunopathology·L R Travassos, I C Almeida
May 7, 2021·Microbes and Infection·Camila Macedo MedinaAlexis Bonfim-Melo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.